President Joe Biden's term ends in 2025. His administration proposed a new rule to address obesity by expanding Medicare and Medicaid coverage for weight-loss drugs Ozempic and Mounjaro. This led to a rise in stock prices for Novo Nordisk and Eli Lilly.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing